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Bile acids in the small intestines of animals serve to breakdown fats and fatsoluble vitamins. Most of the bile acids are reabsorbed into the enterohepatic circulation,
but approximately five percent of these bile acids pass into the large intestine. These bile
acids are swiftly deconjugated by the bacterial population, and then subjected to further
intestinal bacterial chemical modifications. The most significant of these modifications
are 7α-dehydroxylations which form secondary bile acids (deoxycholate and
lithocholate). Much research has illuminated the 7α-dehydroxylation pathway: of
particular interest is the bile acid inducible operon, for which Clostridium scindens VPI
12708 serves as the model organism. There is a lack of knowledge on how this operon is
regulated, so the goal of this project was to create a genetic construct consisting of
upstream regulatory elements, a bile acid inducible promoter, and a ϐ- glucuronidase
reporter. Cloning strategies utilized PCR to amplify desired DNA fragments and sewing
methodology to combine DNA fragments. DNA fragments were ligated into plasmids
and transformed into competent E. coli . Transformants were evaluated for the desired
reporter gene fusion by blue/white screening, additional PCR, and/or restriction
digestion. The bile acid inducible promoter was successfully amplified, and the upstream
sequence and uidA (ϐ- glucuronidase) reporter was demonstrated. However, no E. coli
iv

transformants were demonstrated to possess the bai P-uidA gene fusion. The project
strategy is plausible and data regarding the bile acid inducible promoter are greatly
needed.
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Introduction

An important function of the liver is the synthesis of bile. Bile composition is
composed of organic and inorganic electrolytes, calcium, magnesium, sulfate,
phospholipids, proteins, cholesterol, and bile acids. Bile secretion by hepatocytes serves
as an excretion route for organic solutes (e.g. bilirubin) and assists in lipid and fat-soluble
vitamin absorption (Scharschmidt 1990). Lipids and fat-soluble vitamins are hydrophobic
and will form larger insoluble aggregates in aqueous solutions. Bile acids prevent
aggregation of these compounds and promote lipid emulsification so that these can be
broken down into ever smaller sizes (Monte et al. 2009).
Bile A cid Biochemistry
In vertebrates, hepatic biosynthesis of primary bile acids provides an elimination
route for cholesterol. Cholesterol (Fig. 1) comprises the basic ‘chemical chassis,’ a 19carbon sterol nucleus of bile acid compounds (Vlahcevic et al. 1990). Key chemical
groups attached to the sterol nucleus include a carbon side chain (bonded at carbon 17)
that includes a branched 5 carbon side chain ending in a carboxylic acid, 5β hydrogen,
and a 3α hydroxyl (Samuelsson 1960; Vlahcevic et al. 1990). Therefore, the primary bile
acids are 24-carbon cyclopentanephenanthrene sterols and include cholic acid (3α, 7α,
12α-trihydroxy-5β-cholanic acid) and chenodeoxycholic acid (3α, 7α-dihydroxy-5βcholanic acid) (Vlahcevic et al. 1990; Monte et al. 2009).
The primary bile acids (Fig. 1) function as ionic detergents to aid the
solubilization of cholesterol and other organic compounds such as bilirubin, and the
absorption of dietary lipids and lipid soluble vitamins (A, E, D, and K). In humans, after
3
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synthesis within the liver, primary bile acids are stored in the gall bladder, awaiting a
postprandial cholecystokinin cue. Cholecystokinin is a polypeptide that stimulates the
gall bladder to contract and to empty accumulated bile acids into the duodenum. Research
suggests that the bile acid pool cycles from hepatic origin, to the gall bladder, to the small
intestine, and back to the liver via the portal vein. This enterohepatic circulation occurs
twice per meal. Predictably, bile acid re-absorption is most efficient in the ileum,
allowing the detergent action of these compounds to be effective throughout the length of
the small intestine. Re-absorption is efficient; 95% of the bile acid pool is returned to the
liver via the portal vein (Hill and Drasar 1968; Vlahcevic et al. 1990). Any deconjugated
bile acids are reconjugated before the liver resecretes these into the bile and completes
the enterohepatic circulation (Prabha and Ohri 2006). The remaining 5% (~400 – 600
mg/day) enter the large intestine and are modified by intestinal microbes (Hill and Drasar
1968; Vlahcevic et al. 1990).
Within the liver, >99% of primary bile acids are conjugated to different
modifying groups (amino acids, sulfates, glucuronides, etc.). Conjugation with either
glycine or taurine occurs most frequently at C24 (Vlahcevic et al. 1990; Vlahcevic et al.
1992). Modifying groups are linked via ester, ether, or amide bonding to either side chain
carboxyls or one of the hydroxyl groups of the steroid rings. These chemical
modifications prevent precipitation of the primary bile acids under neutral aqueous
conditions (Hill and Drasar 1968; Vlahcevic et al. 1990; Russell and Setchell 1992;
Vlahcevic et al. 1992; Ridlon et al. 2006). The average concentration of bile acids is 12
g/L in human hepatic ductal bile. Cholates, deoxycholates, and chenodeoxycholates
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represent 35%, 25%, and 35%, respectively, of primary bile acids in human bile
(Vlahcevic et al. 1990).
The intestinal microflora consist of a diverse group of bacteria estimated at a
density of 1 x 1012 colony forming units (CFU)/g and consisting of over 500 species
(Lievin-Le Moal and Servin 2006; Canny and McCormick 2008). Notable genera include

Bifidobacterium, Escherichia, Clostridium, Bacteroides, Streptococcus, Fusobacteria,
Peptostreptococcus, Lactobacillus, Methanobrevibacter, Helicobacter, and Enterococcus
(Lievin-Le Moal and Servin 2006; Canny and McCormick 2008; Huys et al. 2008).
Microbial populations become increasingly numerous and anaerobic toward the distal end
of the intestinal tract. These microorganisms perform useful functions for the host
including vitamin synthesis, protection from exogenous pathogens, and fermentation of
non-digestible carbohydrates (Canny and McCormick 2008). Additionally, these
microbes are known to modify bile acids that escape reabsorption by the ileum.
There are several potential microbial modifications that can occur to the bile acids
that enter the large intestine. Intestinal microorganisms that possess bile salt hydrolases
perform deconjugation (the removal of amino acids from primary bile acids) which
provides an available source of carbon, nitrogen and sulfur (Ridlon et al. 2006). For
example, taurine is known as both an aerobic and anaerobic energy source, and glycine is
used in an amino acid fermentation reaction in which one amino acid donates electrons to
a different amino acid. Other post-deconjugation biotransformations result from 7αhydroxysteroid oxidoreductases, 7β- dehydroxylases, 12α/β hydroxysteroid
dehydrogenases, and 3α-hydroxysteroid oxidoreductases (Vlahcevic et al. 1990; Ridlon et
al. 2006). However, it is the irreversible action of 7α-dehydroxylases, which is deemed
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the most important quantitative microbial modification, that require careful consideration
(White et al. 1980).
The 7α-dehydroxylation activity is notable because of the prevalence of
secondary bile acids (Fig. 1) in human feces. Deoxycholic acid (3α,12α-dihydroxy-5βcholan-24-oic acid) (DCA) and lithocholic acid (3α-hydroxy-5β-cholan-24-oic acid)
(LCA) (produced via dehydroxylation of cholic acid (CA) and chenodeoxycholic acid
(CDCA), respectively), can only be transformed after deconjugation (Ridlon et al. 2006).
Secondary bile acids differ functionally from the compounds from which they are derived
because these do not solubilize lipids on par with CA/CDCA. In addition, secondary bile
acids are more cytotoxic and carcinogenic than primary bile acids, and these alter
biosynthesis of primary bile acids (Franklund et al. 1993). Biochemically, secondary bile
acids are significantly more hydrophobic than primary bile acids after microbial
modifications (Nihira et al. 1988; Lamcharfi et al. 1997).
Primary bile acid 7α-dehydroxylation results in a net reduction of two electrons.
This large, energetically expensive pathway is thought to benefit 7α-dehydroxylating
organisms by giving these a competitive edge against other organisms that are susceptible
to the cytotoxicity of secondary bile acids and/or by providing an energetic advantage in
using bile acids as electron acceptors to dispose of electrons from other metabolic
processes (Ridlon et al. 2006).
It is noteworthy that only a tiny percentage of the colonic microbiota (~0.0001%)
possess the 7α-dehydroxylation pathway, yet the conversion rate from primary to
secondary bile acids is relatively rapid (Ridlon et al. 2006). Equally noteworthy is that the
genus that is most often implicated in 7α-dehydroxylations within the intestine is
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Clostridium (Midtvedt and Norman 1967; Ferrari et al. 1977; Stellwag and Hylemon
1979; Hirano et al. 1981; Takamine and Imamura 1995; Doerner et al. 1997). The
presence of Clostridium species was confirmed by 16S rDNA analysis of fecal 7α-DH
bacterial isolates (Wells et al. 2000; Ridlon et al. 2006).
Elevated levels of secondary bile acids have been found in patients with
gallstones and in colorectal patients (Hill et al. 1975; Nagengast et al. 1988; Berr et al.
1996). One study focused on cholesterol gallstone patients with elevated biliary
cholesterol and DCA implicated 7α-dehydroxylating bacteria in the formation of
gallstones (Berr et al. 1996). Additionally, 70% of large bowel cancer patients exhibited
high levels of fecal bile acids and Clostridia capable of modifying primary bile acids as
compared to 9% of the non-cancer patients (Hill et al. 1975).
Secondary bile acids re-enter enterohepatic circulation after passive reabsorption
in the colonic mucosa. The liver is unable to convert LCA and DCA back into CDCA and
CA. The process of 7α-hydroxylation is not performed on returning bile acids. Instead,
upon return to the liver, LCA and DCA are conjugated with either glycine or taurine.
LCA is also often sulfated on the third carbon of its sterol rings (Hofmann 1984; Ridlon
et al. 2006).

Clostridium and Bile A cid Metabolism
Clostridum scindens VPI 12708 is the model organism for studying the bile acid
inducible operon and elucidating the genes and proteins involved in the transformation of
primary bile acids into secondary bile acids (Coleman et al. 1988; White et al. 1988a;
White et al. 1988b; Krafft and Hylemon 1989; Mallonee et al. 1990; Mallonee et al.
1992; Franklund et al. 1993; Mallonee et al. 1995; Mallonee and Hylemon 1996; Ye et al.
1999; Kang et al. 2008). The organism of interest for this project was renamed
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Clostridium scindens VPI 12708 (previously Eubacterium VPI 12708) based on
phylogenetic comparison (Kitahara et al. 2000).

Clostridium scindens VPI 12708 initiates the bile acid 7α-dehydroxylation
pathway by importing primary bile acids intracellularly via a bile acid transporter
(Mallonee and Hylemon 1996). After importation, bile acid-CoA ligase adds co-enzyme
A on to the bile acid carboxylic acid group (Mallonee et al. 1992). If cholic acid is
present, modification by a 3α-hydroxysteroid dehydrogenase produces 3-oxo-cholyl-CoA
(Mallonee et al. 1995). Modification by a 3-dehydro-4-CA steroid reductase produces 3oxo-Δ4-cholyl-CoA (Franklund et al. 1993), followed by dehydration by a bile acid CoA
hydrolase (Ye et al. 1999). The resulting 3-oxo-Δ4-cholic acid is further dehydrated by
7α-dehydratase (Wells and Hylemon 2000). This 3-oxo-Δ4,6-deoxycholic acid
intermediate is converted into 3-oxo-Δ4-deoxycholic acid, into 3-oxo-deoxycholic acid,
and ultimately into deoxycholic acid after accepting electrons from NAD(P)H. The
specific enzymes involved in each of these steps have not been yet. Lastly, the resulting
secondary bile acid is hypothesized to be removed from the cell via a bile acid exporter
(Ridlon et al. 2006).
In earlier scientific work, the first reports of 7α-DH induction among Clostridium
species VPI 12708 stated that amending growth media with [C14] – CA or [C14] – CDCA
induced 7α-DH activity. Induction was measured radiochromatographically by rate of
formation of [C14] – DCA or [C14] – LCA. Notably, this induction was specific in that
both a free C-24 carboxyl group and a free 7α-hydroxyl group were required (White et al.
1980).
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The bile acid inducible operon (Fig. 3) is a 12 kb gene regulation system that
encodes at least 8 structural genes, a bile acid inducible promoter, and two upstream araC
homologous regions which may serve to regulate transcription (Wells and Hylemon
2000; Ramasubbaiah 2004; Ridlon et al. 2006). The bai genes are ordered after the
promoter as follows: bai B, bai CD, bai E, bai A2, bai F, baiG , bai H, and bai I. Additional

bai genes are still expected to be discovered. The mechanism of the bai operon regulation
is unknown (Ridlon et al. 2006).
An attempt to understand the genetic regulation of 7α-DH expression began with
the discovery of two cholic acid induced polypeptides (45 kDa and 27 kDa) which led to
the cloning of the gene encoding the 45 kDa protein. Additionally, a Northern blot
revealed a cholic acid induced >6,000 nucleotide mRNA which suggested the possibility
of a large bile acid-inducible (bai ) operon (White et al. 1988a). The discovery of the
previously mentioned 27 kDa protein led to the cloning of a second gene implicated in
the 7α-DH pathway (Coleman et al. 1988). DNA sequence analysis revealed an open
reading frame upstream of the 45kDa gene that could encode a second protein. An
additional 27kDa polypeptide was discovered and a comparison of these two 27kDa
genes (temporarily designated as 27K-1 and 27K-2) revealed homology within nucleotide
sequences; the deduced amino acid sequences were also homologous. The discovery of
these polypeptides suggested a multigene family, the existence of and the need to clone
an entire operon, and the need to elucidate the function of all the implicated polypeptides
(White et al. 1988b). Genes 27K-1 and 27K-2 were renamed to bai A1 and bai A2,
respectively. A third gene (bai A3), which is not part of the operon and exists on a
separate chromosomal fragment, was found to be 100% identical to bai A1. This
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determination was followed by the discovery of six bile acid-inducible polypeptides and
their respective DNA fragments that constitute an operon (Mallonee et al. 1990). One of
these six DNA fragments was subcloned into Escherichia coli and shown to encode an
ATP-dependent bile acid-coenzyme A ligase by activity; this gene’s designation is bai B
(Mallonee et al. 1992). A second fragment, Bai H, encodes a NADH:Flavin
oxidoreductase (Franklund et al. 1993). Four additional fragments were designated

baiA1, baiA3, baiE, and baiG. Further study of bai A1 and baiA3 revealed 3αhydroxysteroid dehydrogenases with specific activity toward coenzyme A-containing
moieties, especially cholyl-CoA and deoxycholyl-CoA (Mallonee et al. 1995). BaiE
codes for a bile acid 7α-dehydratase (Dawson et al. 1996), and Bai G codes for a bile acid
transporter, presumably driven by the proton motive force, which specifically recognizes
CA and CDCA as substrates (Mallonee and Hylemon 1996). The bai F gene encodes a
bile acid co-enzyme A hydrolase (Ye et al. 1999). Most recently, bai CD was found to
have a stereo-specific NADH-dependent 7β-hydroxy-3-oxo-Δ4-cholenoic acid
oxidoreductase activity. Bai I is predicted to encode a 7β-dehydratase based upon
comparison with the bai E gene (Kang et al. 2008). Figure 2 reviews the structural
transformations involved in 7α-DH.
The homodimeric AraC protein functions as both a positive and negative
regulator for the uptake and metabolism of L-arabinose. In E. coli , dimeric AraC binds
near the ara promoter site and forms a loop in the DNA that represses transcription when
L-arabinose is absent. If the sugar is present, AraC changes its binding at the promoter to
directly interact with RNA polymerase and activates genes under the control of the ara
promoters which converts L-arabinose to D-xylulose phosphate (Schleif 2003). AraC
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regulation is relevant regarding the DNA sequence (~1200 bp) that precedes the bai
promoter because it is homologous to araC. Figure 4 shows a clustal W alignment of

araC homologous sequences within several bacterial species. If it regulates in a similar
manner, then it will be necessary to include this DNA upstream of the bai promoter for
functionality.
The specific aims of this project were as follows: 1. To create a reporter gene
fusion containing the bai promoter, potential regulatory sequence, and the uidA reporter
gene, and 2. To test for the regulation of expression of the reporter gene fusion by
primary bile acids. We hypothesized that the addition of araC homologous sequence
upstream of the bai promoter would make no difference in governing response to bile
acids and that there would be no difference in bai operon activity in the presence or
absence of primary bile acids.
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M aterials and Methods

Bacterial Strains
The model organism, Eubacterium VPI 12708 (White et al. 1980), was renamed

Clostridium scindens VPI 12708 by Kitahara et al. in 2000. The organism was originally
obtained from Dr. Philip Hylemon from Virginia Commonwealth University.

Media

E. coli strains were grown aerobically in Luria-Bertani (LB) media consisting of
10 g tryptone (Fisher Scientific; Pittsburg, PA), 5 g sodium chloride (Fisher), and 5 g
yeast extract (Becton Dickinson; Franklin Lakes, NJ) per liter. LB media were autoclaved
and stored at ambient temperature. For plates, 15 grams of granulated agar (Fisher Sci)
was added to LB media prior to autoclaving (Ausubel et al. 2002).

Clostridium scindens VPI 12708 was cultured anaerobically in Brain Heart
Infusion (BHI) (Becton Dickinson) with modification (Holdeman et al. 1977).
Amendments to 37g BHI included (per liter): 40 mL VPI salt solution, 1 mL hemin , 4
mL resazurin solution, 10 g yeast extract (Becton Dickinson), 2 g fructose (Sigma
Aldrich; St. Louis, MO), 1 g cysteine-HCl (Sigma Aldrich), 2.69 g sodium bicarbonate
(Sigma Aldrich), and q.s. NANOpure® (np) water (Barnstead; Dubuque, IA). Hemin
solution consisted of 0.2 mg hemin chloride (ICN Biomedicals), 10 mL 1 M sodium
hydroxide, and 90 mL np water. This solution was autoclaved and stored at 4°C. The
resazurin solution consisted of 25mg resazurin (Sigma Aldrich) in 100 mL np water. All
contents except hemin, cysteine-HCl, and sodium bicarbonate were added to a 2 L round
12

13
bottom flask and boiled while sparging with nitrogen gas. Boiling was ceased after the
resazurin indicator became transparent and the solution cooled to ambient temperature.
Hemin, cysteine-HCl, and sodium bicarbonate were added and mixed; pH was adjusted to
7.0 drop-wise with HCl. Contents were transferred to 18 x 150 mm anaerobic culture
tubes (Bellco Glass; Vineland, NJ), sealed with serum stoppers with a nitrogen head
space, secured with aluminum seals, crimped, autoclaved and stored at ambient
temperature.
VPI salt solution contained (per liter): 0.26 g calcium chloride dihydrate, 0.48 g
magnesium sulfate heptahydrate, 1 g dipotassium phosphate, 1 g potassium dihydrogen
phosphate, 10 g sodium bicarbonate, 2 g sodium chloride. This solution was adjusted to
pH 7.5 with NaOH and stored at 4°C (Holdeman et al. 1977).

A ntibiotics
Ampicillin (Sigma) stocks were made by adding 100 mg ampicillin per milliliter
to a 1:1 np water/ 100% ethanol solution. Tetracycline (Sigma) stocks consisted of 10 mg
tetracycline per milliliter of ethanol. Chloramphenicol (ICN Biomedicals) stocks
consisted of 20 mg chloramphenicol per milliliter of ethanol. Working concentrations in
media are stated in Table 1. All stocks were stored unfiltered.

Plasmids
Bannam and Rood (1993) constructed versatile shuttle vectors to transfer genetic
material in between E. coli and C. perfringens. This (Doerner) laboratory has
demonstrated conjugal gene transfer of pECU-001 (modification of pJIR750) from E. coli
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S17-1 to C. scindens VPI 12708 of pECU-001 (which is a modified pJIR750 (Fig. 5))
(Ramasubbaiah 2004). Plasmid pWKU-001, derived from the pECU-001 plasmid, was
also conjugally transferred. Additions to pECU-001 include a 195 bp cloned bile acid
inducible promoter region from C. scindens VPI 12708 which is upstream of the 1811 bp

uidA gene (Ramasubbaiah 2004).
Plasmid recovery was accomplished using either the UltraClean™ Standard Mini
Plasmid Prep Kit (Mo-Bio; Carlsbad, CA) or a Plasmid Midi kit (Qiagen; Valencia, CA).
When using the Midi preps, purified plasmid DNA was concentrated using centricon
devices (Millipore). Briefly, each sample was diluted in 2 mL np water, placed into a
centricon spin filter, and subjected to centrifugation (1.0 x g, ambient temperature, ≥ 15
minutes). The resulting DNA concentration was determined with a NanoDrop ND-1000
(Thermo Scientific) spectrophotometer measuring absorbance at 280nm.

E lectrophoresis and V isualization of Agarose Gels
Agarose gels were prepared at 1% (grams per 100 mL) agarose (Fisher) in 1x
tris acetate disodium ethylenediaminetetraacetate (TAE) buffer (Ausubel et al. 2002).
TAE was prepared in a 50x concentration as follows (per liter): 242 g Tris base (2-amino2-hydroxymethyl-propane-1,3-diol (Fisher)), 57.1 ml concentrated glacial acetic acid
(Fisher), and 100 ml 0.5 M disodium ethylenediaminetetraacetate (Sigma Chemical), pH
8.0 (Ausubel et al. 2002).
DNA was visualized using Sybr Green I stain (Cambrex Bio Science; East
Rutherford, NJ). Briefly, 10,000x Sybr Green was diluted 1:100 in dimethyl sulfoxide
(DMSO) and 1 µL was directly added to every 10 µL of loading buffer containing DNA.
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DNA bands were observed using a Kodak EDAS transilluminator and processed with
Kodak’s Scientific Imaging System.

L igation and Blunt E nding Reactions
Removal of DNA overhangs was accomplished using an End-It™ DNA Repair
kit according to the manufacturer’s instructions (Epicentre; Madison, WI).
Approximately 1 µg of DNA was used for reactions; reactants were mixed and incubated
at room temperature. Reactions were deactivated by heating to 70°C for 10 minutes.
All ligation reactions were performed using a Fast-link™ DNA ligation kit
(Epicentre). DNA concentrations near 1 µg were used in reaction vessels; reactants were
combined and reactions were conducted at room temperature. Reactions were stopped by
heating to 70°C for 15 minutes.

Gel Purification
After gel electrophoresis, DNA fragments were visualized on an ultraviolet
illuminator (Fisher), excised, and transferred to 1.5 mL snap cap tubes. Gel purifications
were performed using the Wizard® SV Gel and PCR Clean-Up System (Promega;
Madison, WI).

Primers
All primers were designed using Vector NTI software (Invitrogen; Carlsbad, CA)
and synthesized by Integrated DNA Technologies. Primer sequences were as given in
Table 2.
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E nzymes
All restriction exonuclease enzymes used in this project were from Promega
(Madison, WI) and were used as recommended by the manufacturer. Prior to ligation,
restriction enzymes were inactivated by required heating to 65-75°C.
An APex™ heat-labile alkaline phosphatase (Epicentre) was used for cloning
procedures to prevent self-ligation of DNA fragments.

Blue-W hite Screening
Blue-white screening allows for a qualitative detection of a disrupted lac Z genecontaining plasmid within E. coli . The lac Z gene codes for beta-galactosidase which can
hydrolyze X-gal (5-bromo-4-chloro-3-indolyl-[beta]-D-galactopyranoside) into a visible
blue product. This reaction includes the addition of isopropyl-beta-Dthiogalactopyranoside (IPTG) which acts as a synthetic analog of lactose that functions to
inactivate the lac repressor (Yanisch-Perron et al. 1985).
Competent XL-1 Blue E. coli strains are engineered to produce the C-terminal
beta galactosidase fragment. Transforming these E. coli with pUC18 (Fig. 6) plasmids
allows the organism to make the N-terminal beta galactosidase fragment. The N-terminal
portion of the lac Z gene contains a multiple cloning site in the pUC18 plasmid. If this
gene is disrupted by a DNA insertion, the gene will no longer function. For this method,
LB plates were supplemented with 100µg/mL ampicillin, 40 µL of 20 mg/mL X-gal, and
40 µL of 100 mM IPTG. These chemicals were spread using a sterile glass spreader over
the surface of the plate. E.coli transformants were plated and incubated at 37°C for 24
hours. Blue colonies were disregarded, but white colonies were sub-cultured and checked
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for recombinant plasmids by plasmid recovery, endonuclease digestion, and PCR
(Yanisch-Perron et al. 1985).

Sewing Reactions
The technique referred to as “sewing” denotes the joining of two separate DNA
fragments resulting from 15 to 20 base-pair complementation between the 3’ end of one
DNA fragment and the 5’ end of another (In this case, fragments that contain the araC
homolog, bai promoter, and uidA reporter sequence). The barA -bai P fragment has a 3’
DNA overhang possessing complementary base pairs to that of the joining 5’ uidA DNA.
PCR cycler settings: 1. 95°C, 2” 2. 95°C, 30 s 3. Cool 1°C /s until 40°C, hold 1” 4.
74°C, 2” 5. Repeat steps #2 – #4 thirty times 6. 74°C, 10” 7. Cool to 4°C. The newly
combined DNA was amplified using outside primers and Taq polymerase.
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Results and Discussion

The ultimate goal of this project was to create a reporter gene construct under the
regulatory control of the Clostridium scindens VPI 12708 bile acid inducible promoter.
This construct was designated pWKU-003. The synthesis of a functioning construct will
be an excellent tool for investigating the bai operon and for achieving a better
understanding of the process of 7α-dehydroxylation.
Though several publications address the bile acid inducible operon, bai genes, and
bile acid operon inducibility (White et al. 1988b; Gopal-Srivastava et al. 1990; Mallonee
et al. 1990), none address regulation of the promoter. The bile acid inducible operon is
activated in the presence of cholic acid or chenodeoxycholic acid, but the complete
regulatory mechanism is unknown. The bai promoter is approximately 254 nucleotides in
length (Ridlon et al. 2006). We chose to include an additional ~1200 nucleotides
upstream of the bai promoter due to the possibility that this region may contain
regulatory elements necessary for the function of the promoter. Ridlon et al. (2006)
reported two regulatory elements, barA and barB, preceding the bai promoter that are
homologous to araC. A baiP/uidA construct that omitted upstream regulatory elements
previously assembled in this (Doerner) laboratory did not provide evidence of gene
activity as measured by a GUS spectrophotometric assay. We hypothesize that this
construct failed due to the absence of upstream regulatory elements since this construct
consisted of only the promoter and reporter (Ramasubbaiah 2004).
The uidA reporter gene has been widely used in genetics systems to assess
promoter activity (Jefferson et al. 1987; Klijn et al. 2006). The uidA gene codes for β18
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glucuronidase, a hydrolase that breaks down β-glucuronides. This stable hydrolase
enzyme cleaves a substrate (p-nitrophenyl β-D-glucuronide); the end product is
quantified with a spectrophotometer (Jefferson et al. 1987). Our project’s special
consideration is the fact that we are using an obligate anaerobe. The uidA gene is a viable
reporter for this project because Feldhaus et al. (1991) successfully employed the uidA
reporter in Bacteroides, an obligate anaerobe.
The bile acid inducible promoter and upstream sequence were amplified from C.

scindens VPI 12708 chromosomal DNA (5’ primer = Up AraC/bai (1), 3’ primer = Dn
AraC-bai or Downstream AraC-hol). The restriction sites on the barA 5’ end (Bgl II) and
the uidA 3’ end (Ba mH1) allow for future excision from the pWKU-001 plasmid (Fig. 5,
7). Fifteen uidA-complementary bases were added to the barA-bai P 3’ end to allow these
fragments to be sewn together. A high fidelity Tli DNA polymerase (Promega) was used
to amplify these sequences from C. scindens VPI 12708 (barA -bai P) and pWKU-001
(uidA). The data (Fig 8A) show that the barA -bai P (lane 5, ~1,500 bp) and uidA (lane 1,
~1800 bp) fragments were amplified. A 16s RNA gene was amplified as a template
control to confirm the presence of bacterial DNA (Primers = 27f, 1492r; Fig 8A, lane 2).
The sewing of these amplicons together was unsuccessful (Fig 8B, lane 1) since a ~2,000
bp fragment was visualized, but the expected ~3,300 bp DNA fragment was not detected.
A plausible explanation for this failure could be that the annealing reaction was
inefficient. The current protocol adjusted temperature from 95°C down to ~40°C in a
matter of seconds. A gradual temperature decrease over two minutes following
denaturation might enhance the joining of the two DNA fragments by promoting greater
base pair complementarity. A second possibility is that both Taq and Tli have
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exonuclease activity which might degrade the 3’ overhang on the barA - bai P DNA. This
partial success, the amplification of the barA-bai P and the uidA fragments, led to the next
protocol variation which used a different sewing polymerase but preserved the protocol
strategy.
Since the amplicons that were to be joined were successfully amplified, a
modified cloning strategy was developed. The second cloning protocol (Fig 7) also
produced the previously mentioned DNA amplicons as seen in Fig 9A, lanes 1 and 2.
Most steps were identical to the previous protocol, but Klenow polymerase was used
instead of Taq or Tli . Klenow polymerase lacks 5’ to 3’ exonuclease activity and
therefore better preserves the 3’ overhang in the AraC/bai P fragment. For gradual cooling
following deannealing (the separation of double stranded DNA), the temperature was
reduced by five degrees Celsius every 30 seconds until holding at 37°C. Klenow
polymerase, nucleotides, and buffer were added; reactions were incubated at 37°C for 30
minutes and were then amplified by flanking primers. Fig 9B shows the final
amplification result of four different reaction mixtures in lanes 2 – 5. Even with this
modification, a ~3,300 bp fragment was not recovered. Repeated attempts to amplify
these reaction mixtures with flanking primers were unsuccessful (data not shown).
It is not possible to confirm whether the Klenow polymerase successfully filled in
nucleotides after the barA-bai P and uidA fragments were sewn. This approach did not
control for the template amplification limit of Taq polymerase (0.2 kbp to 2.0 kbp, which
was not known until the fourth cloning protocol was devised (Unknown 2007)).
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The third cloning protocol (Fig. 10) amplified a 120bp fragment from the uidA
gene contained within pWKU-001 (Fig. 11A, lanes 1 – 3). The barA-bai P fragment was
amplified from C. scindens VPI 12708 as described previously (Fig 11A, lanes 5 and 7).
During the second round of PCR amplification, the barA -bai P fragment with its 3’ uidA
complementary bases and the 120 bp uidA fragment were sewn, and then amplified using
the upstream AraC primer and the uidA (2) as the downstream primer (Fig. 11B). Several
annealing temperatures (51.5°C to 64.6°C) were employed but this range seemed to have
had no effect on the outcome (Fig. 11B; lanes 1 – 7, 9 – 16). We did observe that the
polymerase used in the amplification reactions (Taq versus Tli ) affects the amplified
products; a clear difference can be seen by comparing the bands seen in Fig. 11B. Two
amplicon sizes were observed when Taq was used (~1,100 and ~1,600 bp) and several
amplicons were observed (~100, 300, 700, 1000, and 1600 bp) when Tli was used. The
~1,600 bp band is the expected fragment size; this PCR product was gel purified and cut
with BclI. The pWKU-001 plasmid was cut with EcoR1, blunt ended (5’ and 3’ DNA
ends do not have overhangs), and cut with Bcl1. The restriction enzymes remove the
existing bai P and first 120 bp of the uidA gene from pWKU-001. This also allows for a
directional ligation of the ~ 1,600 bp fragment insert (also cut by Bcl1) into the cut
pWKU-001. The vector and the barA-bai P-uidA fusion were transformed into E. coli
XL1 Blue and grown on LB agar with ampicillin, ITPG, and X-gal.
Putative transformant E. coli were screened using whole colony PCR to confirm
the presence of the desired pWKU-003. All of the amplified fragments were smaller than
expected (Fig. 11C). Since colony PCR was unsuccessful, two colonies (L4-2, L1-2)
were selected for further analysis. Plasmids were recovered from transformants, cut with
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EcoR1 and analyzed for the presence the proposed 10.6 kbp pWKU-003 (Fig. 12A). Two
plasmids seen in Fig. 12A, lanes 1 and 5, exhibited fragments running near the expected
size of 10.6 kbp (pWKU-001 after digestion = ~9,000 bp, insert = ~1,600 bp). However,
upon a secondary, confirmatory HindIII digestion of the same plasmids (Fig. 12A, lanes 1
and 3), transformants exhibited fragments of ~3 kbp and ~5.5 kbp, respectively, instead
of the expected 10.6 kbp band. Further PCR amplification confirmed the presence of the

uidA gene, but could not confirm the presence of baiP or barA sequence (data not
shown).
A previously unknown Bcl I site was discovered within the AraC-bai P insert after
analysis with Vector NTI software in assessing the failure to detect the desired full barA-

baiP-uidA fusion. Vector NTI predicts that digestion of the insert with the Bcl I restriction
enzyme should result in two fragments 336 bp and 1151 bp (confirmatory insert digest
not performed). Since the gene fusion was prepared for insertion by Bcl1 digestion, this
would diminish the likelihood that all ~1500 bp of the barA-bai P nucleotides would be
included in the plasmid. In the next method, we also addressed the template size
limitations of Taq polymerase by switching this enzyme in favor of one that can amplify
longer templates with high fidelity.

To overcome the template size limitations of Taq polymerase (which amplifies
templates 0.2 kbp to 2 kbp), a polymerase that can amplify >2 kbp with high fidelity was
obtained, and this led to a fourth cloning strategy (Fig. 13). BarA-bai P (~1500 bp) and

uidA (~1820 bp) were amplified as in previous protocols, but these fragments were
joined using a combination of controlled temperature reduction (-1°C/30s) to 40°C and a
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high fidelity, long amplifying DNA polymerase ( LA Taq; Takara/ClonTech Labs). As
the thermocycler holds 40°C, dNTPs were added before an elongated extension period at
74°C. Primers were added that annealed to the 5’ end of the bar-baiP fragment and the 3’
end of the uidA fragment and results suggest (Fig 14A, lanes 1 and 3) that the sewing
reaction was successful because a 3,300 bp fragment was observed. The blue/white
screening produced twelve candidates that were analyzed by PCR. Unfortunately, none of
these candidates were proven to contain the desired construct. Amplifications using
flanking, uidA, and AraC primers on a prospective colony identified by restriction
enzyme digestion (data not shown) were inconclusive. DNA amplicons of 3,300; 1,800;
and 1,500 bp should have appeared in lanes 1, 2, and 3of the gel (Fig 14B), respectively.
Fig 14B shows that only the uidA amplification (lane 2) was successful; the combined

barA-baiP-uidA (lane 1) and the barA-baiP fragment (lane 3) did not amplify from the
plasmid. No inconsistencies were noted among negative controls. Further attempts to
perform the reaction protocol using an alternate high fidelity DNA polymerase (ABgene
Extensor) instead of LA Taq were unproductive (data not shown).
It is unknown if the failure to clone the complete barA-bai P-uidA fusion was due
to the lack of complete assembly of the construct or if it was due to an incompatibility
issue of introducing a high-copy plasmid containing a foreign set of instructions into E.

coli . High copy plasmids can impose metabolic burdens upon cells and foreign DNA can
impose toxic effects on the host cell (Carnes and Williams 2009). We did address this
possibility by considering a low-copy plasmid for use in future methods.
One alternative cloning possibility would be to amplify the bai P-uidA regions
within the existing pWKU-001 and to design an upstream primer that adds an extra ~20
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bp (complementary to the 3’ barA nucleotides) to the 5’ bai P end. Primers could then be
designed to amplify the barA sequence from C. scindens VPI 12708, and a sewing
reaction can be performed to unite the two fragments. If restriction site locations allow,
ligating the fragment directly into the pWKU-001would be preferable. If not, then the
fragment can be ligated into pBR322.
Ultimately, we succeeded in amplifying the bai P, upstream sequences, and the

uidA reporter. The desired barA-baiP-uidA composite fragment was only produced with
the fourth cloning strategy, but this result was not consistently reproducible. Nonetheless,
this result suggests that the use of a high fidelity, large template amplifying polymerase
and a slow cooling step within the PCR method may be a useful strategy in the future for
constructing a barA-bai P-uidA composite fragment. The use of a simple Taq polymerase
to perform larger amplifications than it was designed to perform was a major flaw in the
experimental design of this study. Since the proposed barA-bai P-uidA construct was not
successfully transformed into E. coli and then mated with C. scindens VPI 12708, no
further information could be ascertained about the bai promoter or operon from this
project. Future studies will be necessary to develop successful cloning protocols that
create bai promoter-reporter gene fusions and allow measurement of bai operon activity.
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T able 1: Stock and working antibiotic concentrations

A ntibiotic Stock
Ampicillin 100 mg/mL

Wor king Concentration
100 µg/mL

Tetracycline 10 mg/mL

10 µg/mL

Chloramphenicol 10 mg/mL

20 µg/mL
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T able 2: Primer labels, length, and nucleotide sequence

Primer Pair I D
Up AraC
Up AraC(2)

L ength
(BPs)
35
36

Dn AraC

48

Dn AraC(2)
Up uidA
Dn uida
Dn uidaKpn1(2)

55
30
32

27f (16S rDNA)
1492r (16S
rDNA)

21
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Primer Seq 5' to 3'
ATAGATCTTCATTGGTTTTCACCTCCCCGGTAGAG
GGAAGATCTTCATTGGTTTTCACCTCCCCGGTAGAG
GTTTCTACAGGACGTAACATTTTCTTAATGCTTAATATCTTTTCTT
CG
GGTTGGGGTTTCTACAGGACGTAACATTTTCTTAATGCTTAATAT
CTTTTCTTCG
ATGTTACGTCCTGTAGAAACCCCAACCCGT
ATGGATCCTCATTGTTTGCCTCCCTGCTGCGG
TTGTAACGCGCTTTCCCACCAACGC
AGAGTTTGATC(AC)TGGCTCAG
ACGG(CT)TACCTTGTTACGACTT
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1.

OH
3.

2.

OH
C-NH-R
O

C-NH-R
O

OH

OH

Primary Bile Acids

4.

OH

OH

5.

OH

C-OH
O

OH

C-OH
O

OH
Secondary Bile Acids

6.
C-OH
O

OH

OH

F igure 1: Structures of cholesterol, primary and secondary bile acids
Cholesterol (1), conjugated chenodeoxycholic acid (2), conjugated cholic acid (3),
lithocholic acid (4), deoxycholic acid (5), and ursodeoxycholic acid (6).
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C-OH
O

bai B
CoASH +
ATP

Chenodeoxycholic acid
OH

OH

C-SCoA
O

C-SCoA
O

baiA
NADP+

OH

OH

baiCD

CDCA-CoA

OH
3-dehydro-CDCA-CoA

NADP+

C-OH
O

C-SCoA
O

baiF
O

baiE

OH
3-dehydro-4-CDCA

O
OH
3-dehydro-4-CDCA-CoA

C-OH
O

C-OH
O
3 NADH

NAD+
OH

3-dehydro-4,6-LCA

LCA

F igure 2: Proposed chenodeoxycholic acid bile acid 7α-dehydroxylation
pathway in Clostridium scindens VPI 12708
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barB

barA

P

baiB

baiC D

baiE baiA2 bai F

baiG

baiH

baiI

bai Operon

F igure 3: Proposed map of the bile acid inducible operon
P designates the bile acid inducible promoter. Genes and functions: barA &B encode
putative transcriptional regulators, baiB encodes bile acid CoA ligase, bai CD encodes 3dehydro-4 chenodeoxy/cholic acid oxidoreductase, bai E encodes7α-dehydratase, bai A2
encodes 3α-hydroxysteroid dehydratase, bai F encodes putative bile acid CoA transferase,
baiG encodes H+ dependent bile acid transporter, baiH encodes 3-dehydro-4ursodeoxycholic/7-epi cholic acid oxidoreductase, and bai I encodes 7β-dehydratase.
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TCATTGGTTTTCACCTCCCCGGTAGAGACTCCGGTATTCGCCAGGCGTCA 50
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TTGGAAA 7

TCTTATAGAGTTTGTTAAAGGCCCTGGAAAAGGAGCGGCTGCAGTTGAAC 100
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ATGGCTGAAGCGCAAAATGATCCCCTG
ATGGCTGAAACGCAAAATGATCCGCTA
ATGTATCAACGCATGGTTCAGGAACCGCAACCCAATCCTTTG
CAATCATGTTACTTAACAATACACTTGAATATATTGAAAGAAATTTGCAT
ATGGAGAGTAAACAAAGTAGAAATGAGTATTTACAGTGCATATACAAA
CCTACATTTACCGCCACATCCAGCACCGGAAGATTCGTCGTAAGCAGAAG
*
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27
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57
48
150
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CTGCCGGGATACTCGTTTAATGCCCATCTGGTGGCGGGTTTAACGCCGA
TTGCCGGGATATTCATTTAATGCCCATCTGGTCGCCGGGCTGACGCCAA
CTGCCAGGCTACACGTTCAATGCTTATCTGGTCGCAGGATTAACCCCGA
ACGGCAATTAATATAGATGATATATCAAAAGTTGCATGTTCATCACGAT
GTACAAAATTATATAGAATTACACATAAATGATTCACTTTCAATTGAAG
GGCTGCAGCATGACGCAGCCTTGTAAGGACGGTGATGTCCTTGTAGGACG
*
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76
91
106
97
200
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TTGAGGCCAACGGTTATCTCGATTTTTTTATCGACCGACCGCTGGGAATG
TTGAAGCGAATGGATATCTGGATTTTTTTATCGATCGTCCGTTGGGCATG
TTCTGGCTGACGGCCCACTCGATTTCTTCATTGATCGGCCTGGCGGCATG
ATCACTTTCAGCGTGTTTTTCATTCATTAACAGGATTTACAGTAACTCAG
AGTTAGCGGATATAGCAGGATTTTCAAAGTATCATTTTCATAGAATTTT
CGCCGAATTTCTCCTGGACCAGTTCCCGGATAACGCTCTCGGACAGATAG
**
*
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156
146
250
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AAAGGTTATATTCTCAATCTCACCATTCGCGGTCAGGGGGTGGTGAAAAA
AAGGGATATATTCTTAACCTGACCATCCGCGGAGAGGGCGTCATTAATAA
AAGGGCTATATTCTGAATTTGACCATTAAGGGGCAGGGGAAGATTTTCGA
TATATAAAAAATCGCAGACTTACCCTTGCCGCAGAGGAGTTGGTTTCAAC
TAAAGGGATAGTAGATGAACCATTATCTCGGTATGTAAACCGATTGAAAC
AGGGATTTGGAGGTATCCTTGATGTCGATGGGAGATGAAAAACTTGCATA
*
*
*
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191
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196
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TCAGGGACGAGAATTTGTTTGCCGACCGGGTGATATTTTGCTGTTCCC
TAATGGCGAGCAGTTTGTCTGTCGGCCTGGCGATATATTATTGTTTCC
TGGTGAAAATACCATCTACAGTAATCCTGGTGATTTACTGTTGTTCTC
AGACAGAAGAATAATTGATATAGCATTGAAATATGGTTATGAAA
TGGAAAGGGCAACAAACCTTCTTACATACCGTTCGGATATGACGATTA
GGAGTGATTCAGCACATCCATCAGCATCTGGCTCATGATCATGCCGCG
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GCCAGGAGAGATTCATCACTACGGTCGTCATCCGGAGGCTCGCGAATGG
GCCGGGCGAGATTCATCACTATGGACGGCATCCGGATGCCAGCGGGTGG
ACCTAAGTCGCCTCACCATTATGGTCGTTCACCGAATAGTGATTGTTGG
GTCCAGAAGCATTTACTAAAGCATTTAAAAGATTACATGGAA
CTAATATCGCTTACCATTTTGGTTTCACAGATTCAGCAGT
GTATACCTTCTCCCCGCTCTCCAGCATCTGCTTGCGATATTCCAGAGGTG
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292
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TATCACCAGTGGGTTTACTTTCGTCCGCGCGCCTACTGGCATGAAT
TATCACCAGTGGGTTTATTTCCGGCCTCGCGCCTACTGGCAGGAGT
TATCACCGCTGGGTCTATTTCCGACCACGGGCTTATTGGGCCGATT
TATCACCATCAGCTTTAAAAAAGCTTAATGGAAAAATTAAAGCTTT
TTTCTCCCGTACATTTAAAAATTATTATGGAGTAAGTCCGTCTCAA
TCGTCCCGGTATATTTCTTAAAGATGCGGTAGAAGGCTACTTCCGAGGAA
*
**
* *
* *

319
319
334
338
330
448
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GGCTTAACTGGCCGTCAATATTTGCCAATACGGGTTTCTTTC
GGCTGACCTGGCCGACAATCTTTGCTCAGACAGGATTTTTCC
GGTTGGAATGGCACAGTAAAACCCATGAGGTAGGGCGTTTATC
TCCCAAAATCTCTTTTCAAATATCTATAAAAGGAGAGTGCGAAATC
TATCGAAACGACAATAGCAAGAATTGCAAAGACGTAAGAAGAATTT
AATCCGGAATGCTCGGCCACGTATGACAGAGACATGTCTTCGTAGAGAAG
*
*
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377
384
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GCCCGGATGAAGCGCACCAGCCGCATTTCAGCGAC
GCCCGGACGAGGCGCGCCAGCCGCATTTCAGCGAA
TTTACCTAACAATAACTTAATGCTGGAGTTTGACCGC
ATTTATAGAATAGTTGAAAAAGAAGCATTTAAGGTAT
CTCAATACAATGAATGTAAGAAGGTTCGAGGGAATGTTGAAAT
CGCGCCGGAAGCGATATTCACCCGTACGCGGTTCAGTGTGTGGGCAAAGT
*
* *
* *
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414
421
419
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CTGTTTGGGCAAATCATTAACGCCGGGCAAGGGGAAGGGCGCTATT
CTGTTCGGGCAGATCATCAGCGCCGGGCAAGGGGAAGGTCGCTATT
TTATTTGCCAATATTGAGCAGACACAGAAATCGGGGCGGCGCTTCG
TTGGTACAGGATTTGAAACAACTAGAATTAATTATGCGGCTTATA
TGTAACAGTAGACAATATAAACGTCGCATACATAAGGCATATCGGTACAT
TGTAGCCGCTGATATTGCGCAGTTCCCGGTTCAGCGTAGAAGCGTTGGTA
*
*
* *
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466
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CGGAGCTGCTGGCGATAAATCTGCTTGAGCAATTGTTACTGCGGCGCAT
CTGAGCTACTGGCGATCAATCTGCTGGAGCAGTTGTTGCTCAGACGTAT
GTGAAGAACTGGGTATGAATTTGCTCGAGCGGTTACTGCTACGAGCAAT
AAGAAATACCAGAATTTATTAATAAGATTTTTAAAGATGGAACACAT
ATGAAGAGTTAACTATAGCTTTTCCGAAAATGATAGAGAAACTATTTCA
GAAAAACGCTCAGCCACGCTCTCGGCCGTAATGTCCTCGGCAAAATGGGA
*
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509
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GGAAGCGATTAACGAGTCGCTCCATCCACCGATGGATAATCGGGTACG
GGCGGTAATTAATGAGTCGTTGCATCCGCCGATGGATAGCCGTGTGCG
GGAAGAAGACCCACTTAGTCCACAACGTATTATGGACCCACGTATTAT
GATAGAATTAATGAAGCATTAGGTAATTCTAAAGGTAGTTTATTAGA
ATACGCAACCAAGCAAAACTATCATGTATTTGAGGATACGAAAGTATT
GCCGATATAAAGGGTTGCCTGCCATCCAAGAGGCCAGTCCTTGTCC
*
*
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560
566
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CGAGGCTTGTCAGTACATCAGCGATCACCTGGCAGACAGCAATTTTGATA
CGATGCCTGCCAGTATATCAG
TGAGGCCTGTCAATTTATTACCGGAAATCTGGCAGGGGAATTACGTA
TGGATTTCATTATGATTTTAAAGAAAATGGTACAAGAAAATATATGA
AACCATTTACCACGATCATCATGAATTTACGGAGGACAATCATTTAAGAA
TGGTCTTTCTGGCTTTGATGGATGCCATGCTTGATGAAAAAGTACGCAAA
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560
604
607
616
744
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TCGCCAGCGTCGCACAGCATGTTTGCTTGTCACCGTCGCGTCTGT

TTGACGAAGTTGCCCGCCATGTTTGCCTATCACCATCACGCTTAG
TGGGATATGAAATACCTAGAACAGAGATATCAGATGAATTTACAA
CAAGTTTATGTATAACAATTCCAGGTGAATCTGCAATAGAAACGAACGA
CTGCCCAAGGATGGAGACCTTTATCAGTGAACTGCCAGGATCGAAGCAGG
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CACATCTTTTCCGCCAGCAGTTAGGGATTAGCGTCTTAAGCTGGCGC

CGCATTTATTCCGTGAACAGGTTGGCATTAATATATTACGTTGGCGT
TACTTCAAGTACCTAAGCTTACATGGGCAGTATTTGAAGGATAT
CATTGGAATAATGGTAATACCTTCAGGCAAGTATGCAGTAGGACAT
AATCTTCCTTTTCAAATTCATCGAATAAATCCCGGATCTTTTGCTGATAT
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GAGGACCAACGTATCAGCCAGGCGAAGCTGCTTTTGAGCACCACCC

GAGGATCAGCGGGTGATCCGGGCGAAATTATTACTGCAAACGACCC
GGGGCTATGCCAGATAACTTGATTATACAGGATATATGGAGACGTATA
TTTGAAATATTCCAAGATGAATATAAAAGAGCATGGGACTTTATA
ACTCCTTCCAGCCGGATAACGGGGAGGGCGACCATAATGGCGTCCACCG

649
652
665
794
681
696
696
711
844
727
742
744
756
893
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GGATGCCTATCGCCACCGTCGGTCGCAATGTTGGTTTTGACGATCAACTC

AAGAGCCAATTGCGACCATTGGCCGGGTGGTAGGCTATGATGACCAACTC
TATTCTGAATGGTTTCCATCCTCTGGATTTGAGCAAGTGGAAGGTCCA
TATGGTGAGTGGCTGCCAAATAGCGGATATAAACCGAGAGACTCA
TATCAGGGCTTGGTTCCCTGAGCGCCAGAAAGGAAGAGAGCGGATAGTCA

777
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TATTTCTCGCGAGTATTTAAAAAATGCACCGGGGCCAGCCCGAGC

TATTTTTCCCGTGTTTTCCGTAAACGAGTGGGGGTCAGCCCCAGC
TGTATTGAAAAAAATTTTTGGAATAATAAAAAACATGATGAATAC
TATCCTTTTGAAGTATATAGAAATGATCCAAAGCAGCATCCAAAGCAT
TACACGCAGATAGACAACTCAAGAGGATCGTCGGAATCCGCTTTGATCGT

E._coli_E24377A_araC
S._enterica_CT18_araC
Y._pestis_CO92_araC
C._botulinum_A_str._ATCC_3502_
B._thuringiensis_konkukian_str
C._scindens_12708_araC_hom

GAGTTCCGTGCCGGTTGTGAAGAAAAAGTGAATGATGTAGCCGTCAAGT

GATTTCAGGCGGCGCAGTATCGAAACTAACTATCCACAACGTACTTTTC
AAATGCGAAGTATGGATTCCCGTAAAAACAAAGTCAATCAATTGGTGA
AAACATATAGTTGATATATATGTACCTATCGAACCTTTTTAA
GAACGTGTGGTACGACTGAAGCCAGACGAAGGTACTCTGTTCAAATGGG

E._coli_E24377A_araC
S._enterica_CT18_araC
Y._pestis_CO92_araC
C._botulinum_A_str._ATCC_3502_
B._thuringiensis_konkukian_str
C._scindens_12708_araC_hom

TGTCATAA 879

GTCCAGCGGACTGGCAGGATAATCAGGGGGCATTGGTGCGGGTTTAA 933


AACTCTACGCCATTGATCGTAATTGTGCCGCATCCGGAATTCACCAGTAT 1092

E._coli_E24377A_araC
S._enterica_CT18_araC
Y._pestis_CO92_araC
C._botulinum_A_str._ATCC_3502_
B._thuringiensis_konkukian_str
C._scindens_12708_araC_hom






GAAAAGGGACTCATTTTCACAGATGGGCGGGGTGATGTCGCTGATGGTAT 1142

E._coli_E24377A_araC
S._enterica_CT18_araC
Y._pestis_CO92_araC
C._botulinum_A_str._ATCC_3502_
B._thuringiensis_konkukian_str
C._scindens_12708_araC_hom






GCTTCTGCAGGCGCAGATATTTGTCCTTTCCGGTAAAGACAGAATGGACA 1192

E._coli_E24377A_araC
S._enterica_CT18_araC
Y._pestis_CO92_araC
C._botulinum_A_str._ATCC_3502_
B._thuringiensis_konkukian_str
C._scindens_12708_araC_hom






GGGCTGCCACAGATGGGCTTGGATTTTATTGTGTTTGGCAT 1233

792
792
801
943
822
837
837
849
993
871
886
885
891
1042

F igure 4: C lustal W sequence alignment
Six bacteria were aligned using clustalW software to compare the putative regulatory
upstream sequence of C. scindens VPI 12708 with other known araC gene types. Identity
positions are denoted with a “*”.

33

A.
biaB Ribosome Binding Site
bai operon mRNA start nt
baiP
EcoRI (9159)

PM B1

KpnI (6)

ApaLI (8489)

BclI (97)

ClaI (7 622)

uidA

ClaI (7 581)

ApaLI (941)

Sma I (7 576)

ApaLI (1266)

AvaI (7 574)

BamHI (1820)

XmaI (7 574)

pWKU 0 0 1

CM (R)

9384 bp

PstI (1842)
HindIII (1850)

LACZ
ApaLI (2072)
ApaLI (2569)

ORI

oriT

B.

REP PROTEIN

AvaI (5182)

F igure 5: Plasmids pJI R750 and p W K U-001
(A) pWKU-001 was constructed from pJIR750 which possesses a chloramphenicol
resistance marker and a partial lacZ gene.
(B)Existing vector pWKU-001 contains the uidA gene and a chloramphenicol resistance
marker (Ramasubbaiah 2004).
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B

A

F igure 6: Vectors for transforming bacteria
Physical and genetic maps of pUC18 (A) and pBR322 (B) cloning vectors. The fully
assembled barA -bai P-uidA construct is intended for blunt end ligation into either pUC18
at the Sma I (blunt) site or into pBR322 at the BamH1 site [cut and blunt ended by EndIt® kit (Epicentre)].
10,000bp
10,000bp

2000bp

2000bp

1000bp
1000bp
500bp
250bp

500bp
250bp
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A. Clostridium scindens VPI 12708
(Chromosomal DNA)

5’

B. pWKU-001

Amplify using Tli
DNA polymerase

■

3’ 15bp overhang

α

3’
BamH1

Bgl II

Bile
⌂
acid
inducible
promoter

Upstream
Sequence
(regulatory)

5’

uidA

β

Deanneal and
Reanneal
3’ 15bp overhang

5’

uidA

Extend upstream araC
homologous-bai P-uidA with Taq,
Tli , or Klenow polymerase
5’
3’

■

3’
5’

β

Amplify with
outside primers

5’

3’
5’
5’

3’
5’
5’

3’
5’

F igure 7: C loning Strategy 1 and 2
Chromosomal DNA from Clostridium scindens VPI 12708 (A) was amplified (5’ primer
(■) = Up AraC/bai (1), 3’ primer (⌂) = Dn AraC or Downstream AraC(2)) for the bile
acid inducible promoter including upstream sequence. A 3’ 15 base pair overhang
complementary to the 5’ uidA sequence was added by the downstream primer to facilitate
the annealing of these two fragments. An existing plasmid, pWKU-001(B), contained the
reporter sequence for uidA. This was amplified (5’ (α) = Up uidA, 3’ (β) = Downstream
uidA Amplication) and purified. Both DNA fragments were combined and an attempt
was made to make them contiguous using outside primers and either Taq, Tli , or Klenow
DNA polymerase. Both strategies use similar methodology, but the second uses Klenow
DNA polymerase for extension.
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1000bp
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F igure 8: Results from first cloning strategy
(A) Lane 1 shows amplification of the uidA reporter sequence from pWKU-001 using Up
uidA and Dn uidA primers (expected size = ~1,800 bp). Lane 2 shows amplification of C.
scindens VPI 12708 for a nearly full-length 16S rDNA product considered universal for
the domain Bacteria using 5’ 27f and 3’ 1492r primers (expected size = ~1,500 bp). Lane
3 contains a 1 kb DNA standard. Lane 4 contains a negative control from a PCR
amplification consisting of Up AraC and Dn AraC primers, Taq polymerase and
nuclease-free water. Lane 5 shows amplification of upstream AraC homologous sequence
and the bai promoter from C. scindens VPI 12708 chromosomal DNA (Primers = 5’ Up
AraC and 3’ Dn AraC; expected size = ~1,500). (B) Attempt to sew the upstream AraC
sequence and bai (bile acid inducible) promoter with the uidA reporter gene. Lane 1
contains a PCR amplification of AraC-bai P and uidA DNA fragments using flanking
primers (Up AraC and Dn uidA). Lane 2 contains a 1 kb DNA standard.
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F igure 9: Results from second cloning strategy
(A) Shows amplification of the barA -bai promoter and uidA reporter using Tli high
fidelity DNA polymerase. Lane 1 shows uidA (pWKU-001 template) amplified by 5’ Up
uidA and 3’ Dn uidA primers (expected size = ~1,800 bp). Lane 2 shows upstream barA
sequence and the bile acid inducible promoter amplified by 5’ Up AraC and 3’ Dn AraC
primers (expected size = ~1,500 bp). Lane 3 contains a 1 kb DNA standard. (B) Shows
result of the amplified sewing reaction of bar A -bai P with uidA by varying the
constituents in the reaction mixture. The sewing reaction in each lane was set up with an
initial reaction volume of 10 µL comprised of the two DNA amplicons and the remainder
in nuclease-free water (Lane 2 = 0.5 µL barA -bai P, 0.5 µL uidA; Lane 3 = 1 µL barA baiP, 1 µL uidA; Lane 4 = 2.5 µL barA -baiP, 2.5 µL uidA; Lane 5 = 5 µL bar A -baiP, 5
µL uidA). These reaction tubes were subjected to 95°C, then temperature was decreased
5°C every 30 sec until reaching 37°C. Buffer, nucleotides, and Klenow polymerase were
added for 30 minute incubation at 37°C. Amplification reactions were set up using
flanking primers (Up AraC and Dn uidA); a 3,300 bp fragment was expected. Lane 1
contains a 1 kb DNA standard.
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A. Clostridium scindens VPI 12708
(Chromosomal DNA)

5’

B. pWKU-001

Amplify using Tli
DNA polymerase

■

5’
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Bgl II

Upstream
Sequence
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Bile
⌂
acid
inducible
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α

3’

3’

5’

5’

uidA
120bp

γ

Deanneal and
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3’ 15bp overhang

5’

5’

■
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uidA(2) primers. Extend with Taq
polymerase.
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γ

Modify with
restriction enzymes
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Cut with Bcl1

5’
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Ligate baiP DNA
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F igure 10: T hird cloning strategy
Chromosomal DNA from Clostridium scindens VPI 12708 (A) was amplified [5’ primer (■)
= Up AraC/bai (1), 3’ (⌂) = Dn AraC or Dn AraC(2)] for the bile acid inducible promoter
including upstream sequence. An existing plasmid, pWKU-001 was used as a template (5’
(α) = Up uidA, 3’ (γ) = Dn uidA (2)) and produced a 120bp uidA fragment that was gel
purified. A second reaction combined this DNA fragment with the barA -bai P DNA
fragment using a PCR cycler program that lowered temperature from 95°C to 40°C by 1°C/
30s. The barA -bai P DNA insert fragment was treated with an End-It kit (Epicentre). Plasmid
pWKU-001 was cut with EcoRI, treated with alkaline phosphatase, and cut with Bcl I. The
AraC-bai P insert was cut with Bcl I. Insert and vector were ligated together.
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F igure 11: Results of the third cloning strategy
(A) The barA -bai promoter and uidA fragment sequences were amplified using Tli high
fidelity polymerase. Lanes 1-3 contains amplifications of the a 120 bp uidA fragment using
5’ Up uidA and 3’ Dn uidA(2) primers. Lane 4 contains a 1 kb DNA standard. Lanes 5 and 7
contain amplifications of upstream barA homologous sequence and the bai P using Up AraC
and Dn AraC primers. Lane 6 shows a negative control from a PCR reaction that contained
Up AraC and Dn AraC primers, Taq polymerase, and nuclease free H2O. (B) Amplifications
of the combined AraC-bai promoter and uidA fragment (~1,600 bp). Lanes 1-7, 9-11
amplified barA -bai P/uidA using Taq DNA polymerase and Up AraC and Dn uidA(2)
primers. Lanes 12-16 amplified barA -bai P/uidA using Tli DNA polymerase. Lane 8
contained a 1 KB molecular standard. Annealing temperature varied as follows: lanes 1, 6,
and 12, 51.7°C; lanes 2, 7, and 13, 55.5°C; lanes 3, 9, and 14, 58.4°C; lanes 4, 10, and 15,
61.8°C; lanes 5, 11, and 16, 64.6°C. (C) Direct PCR whole colony screen of transformant
E.coli : Lanes 1 and 2 were amplified by Upstream AraC and Downstream uidA primers
(~3,300 bp expected) without PCR clean-up. Lanes 3 and 4 were amplified identically,
though the template was subjected to clean-up (Mo-Bio).
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F igure 12: Results of the third cloning strategy (continued)
(A) EcoR1 digests of plasmids recovered from putative transformants (desired size =
~10.6 kbp). Lanes 1, 2, 4, and 5 represent recovered plasmids from isolated colonies.
Lane 3 contains a 1 kb DNA standard. (B) HinDIII digests of two putative transformants
for further confirmation of the attempted ligation of pWKU-001, barA -baiP, and uidA
into the proposed pWKU-003 (expected size = ~10.6 kbp). Lane 1 is a HinDIII plasmid
digest of the same colony as Fig 12A, lane 1. Lane 2 holds a 1 kb DNA standard. Lane 3
is a HinDIII plasmid digest of the same colony as Fig 12A, lane 5.
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F igure 13: Fourth cloning strategy
Chromosomal DNA from Clostridium scindens VPI 12708 (A) was amplified (5’ primer
(■) = Up AraC/bai (1), 3’ (⌂)= Dn AraC or Dn AraC(2)) for the bile acid inducible
promoter including upstream sequence. An existing plasmid, pWKU-001(B), contained
the reporter sequence for uidA. This was amplified (5’ (α) = Up uidA, 3’ (β) =
Downstream uidA Amplication) and purified. Both DNA fragments were combined and
an attempt was made to make them continuous using outside primers and either LA TAQ
or ABGene Extensor (long amplifying, hi-fidelity) DNA polymerase. Amplicons were
further amplified by adding outside primers (5’ primer (Δ) = Up AraC(2), 3’ (β) = Dn
uidA). A pUC18 vector was cut with Sma I and treated with alkaline phosphatase. The
baiP insert was treated with an End-It kit (Epicentre) to ensure a necessary 5’ phosphate
group is present. The vector and insert were ligated using a Fast-link ligation kit
(Epicentre).
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F igure 14: Results from the fourth cloning strategy
(A) Ligation of AraC-bai P-uidA using LA Taq DNA polymerase. BarA -bai P and uidA
DNA were mixed in equal volumes in a PCR tube and deannealed at 95°C. The tubes
were slowly cooled 1°C every 30 seconds until they reached 40°C to bind AraC-bai P 3’
uidA complementary base pairs to the 5’ end of the uidA DNA. LA Taq, buffer, and
dNTPs were added before adjustment to 74°C for 10 minutes. Flanking primers were
added (5’ = Up AraC, 3’ = Dn uidA) to the same vessel to continue an amplification
reaction with multiple deanneal, reanneal, and extension cycles. Lanes 1 and 3 show
ligations of barA-bai P-uidA (~3,300 bp). Lane 2 contains a 1 kb DNA standard. (B) The
barA-baiP-uidA insert generated in (A) was ligated into pUC18. The modified plasmid
was transformed into electrocompetent XL1 Blue E. coli . Transformants were isolated by
blue/white screening. Plasmids were recovered from five different isolated transformants
and cut with BamH1 or HinDIII (data not shown). No clones that were digested showed
the desired ~6,000 bp. Three representatives of the twelve isolates were then selected for
further digestion with Bcl 1 and Bgl2. Clone 5 was selected after cutting because its bands
were near the approximated size (data not shown). The gel in (B) shows the attempted
amplification of the recovered plasmid from clone 5 for barA-bai P-uidA (Lane 1), uidA
(Lane 2), and barA-bai P (Lane 3). Lane 4 contains a 1 kb DNA standard.
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